Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
3 ASX shares I would buy and hold for a decade
⏸️ Investing
Are these the best blue chip shares on the ASX?
⏸️ Investing
3 shares both Warren Buffett and Elon Musk would love
⏸️ Investing
3 revolutionary stocks that could set your portfolio on fire
⏸️ Investing
You now need $200 to buy a Cochlear Limited share
⏸️ Investing
Top broker says CSL Limited should still be on your buy list
⏸️ Investing
3 top healthcare shares to buy in May
⏸️ Investing
5 things to watch on the ASX on Wednesday
⏸️ Investing
Tax troubles see RESMED/IDR UNRESTR shares slide
⏸️ Investing
How the falling dollar is sending CSL Limited & Cochlear Limited to record highs
⏸️ Investing
Morgans slaps add rating on ResMed Inc. shares
⏸️ Investing
Why weak share prices can deliver strong returns
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
